Feb 06, 2024

Northborne Industry Insights | 2023 Review and 2024 Precision Medical Manufacturing Outlook

Northborne Partners is pleased to announce the release of its 2023 Precision Medical Manufacturing Review and 2024 Outlook. This detailed report provides insight into the following areas of medical contract manufacturing:

  • Key learnings from 2023
  • Historical sector M&A activity and valuations
  • Value drivers that influence company-specific transaction multiples
  • Industry landscape and active acquirors

Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We have compiled our 2024 outlook based on real-time experience representing multiple clients in the space and conversations with leading industry participants and executives.

Please see the following link to download Northborne’s Precision Medical Manufacturing 2023 Review and 2024 Outlook: Medical Manufacturing 2023 Review 2024 Outlook

For a copy of the full report, please contact one of the Northborne medical manufacturing services team members below.

Ken Higgins

Mike Hirschberg

Matt Hansen

Website includes transactions completed by Northborne professionals at prior firms.

Contact us to find out how Northborne can drive value and increase the probability of success of your transaction.


212 3rd Ave N, Suite 500
Minneapolis, MN 55401

© 2024 Northborne Partners LLC